Rating Change
Barclays analysts reiterated a Overweight rating on Sotera Health Company (NASDAQ:SHC) on June 24, 2026.
reiterateNASDAQ:SHC
Barclays Reiterates Overweight Rating on Sotera Health Company (SHC)
Rating Change Barclays analysts reiterated a Overweight rating on Sotera Health Company (NASDAQ:SHC) on June 24, 2026. Market Context Sotera Health Company operates in the…
Market Context
Sotera Health Company operates in the Healthcare sector. The stock currently trades at $16.69 with a market capitalization of $4.8B.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Sotera Health Company.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Sotera Health Company
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jun 24, 2026 | Barclays | Overweight | N/A |
| Jun 05, 2026 | Goldman Sachs | Buy | N/A |
| May 06, 2026 | Piper Sandler | Overweight | N/A |
| Apr 14, 2026 | Barclays | Overweight | N/A |
| Feb 24, 2026 | Citigroup | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View SHC Stock Page
Frequently Asked Questions
What does a Overweight rating mean for SHC?
A Overweight rating from Barclays reflects the analyst's outlook on Sotera Health Company (NASDAQ:SHC). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the SHC forecast page.